Financial Performance - Revenue for Q3 2023 reached $5 million, a 19% increase compared to $4.2 million in Q3 2022[15] - Revenue for the nine months ended September 30, 2023, totaled $13.4 million, also a 19% increase compared to $11.2 million for the same period in 2022[15] - UltraMist consumables revenue increased by 24% to $3.1 million, constituting 62% of overall revenues in Q3 2023[15] - Net loss for the three months ended September 30, 2023, was $23.7 million, compared to a net loss of $1.1 million for the same period in 2022, primarily due to non-cash losses on the fair value of derivative liabilities[15] - Adjusted EBITDA loss for Q3 2023 was $0.3 million, an improvement of $1.9 million compared to a loss of $2.2 million in Q3 2022[15] Operational Highlights - 55 UltraMist systems were sold in Q3 2023, an increase from 28 in Q1 2023 and 49 in Q2 2023[15] - Gross margin was 71% for the three months ended September 30, 2023, slightly down from 72% in the same period last year[15] Future Outlook - The company anticipates Q4 2023 revenue will increase approximately 15% to 25% as compared to Q4 2022[17] Corporate Developments - In July 2023, the company issued Asset-Backed Secured Promissory Notes, receiving total proceeds of approximately $3 million[19] - SANUWAVE Health entered into a merger agreement with Sweat Equity Partners and Mercury Life Sciences-affiliated SEP Acquisition Corp in August 2023, with the combined company expected to trade on Nasdaq under the symbol "SNWV"[19]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) August 13, 2024 SANUWAVE Health, Inc. | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Nevada | 000-52985 | 20-1176000 | | (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | | 11495 Valley View Road ...

Financial Performance - Revenue for Q4 2024 reached $10.3 million, a 47% increase compared to $7.0 million in Q4 2023 [15] - Gross profit for Q4 2024 was $8.0 million, a 67% increase compared to $4.8 million in Q4 2023 [15] - Gross margin improved to 77.9% in Q4 2024, up 873 basis points from 69.1% in Q4 2023 [15] - Operating income for Q4 2024 was $2.5 million, a 150% increase compared to $1.0 million in Q4 2023 [15] - Adjusted EBITDA for Q4 2024 was $3.655 million, compared to $0.664 million in Q4 2023 [16] UltraMIST System - UltraMIST system saw continuous revenue growth with strong year-over-year growth throughout 2024 [18] - The company had 1,047 UltraMIST systems in the field at the end of Q4 2024 [20] - 135 UltraMIST systems were sold in Q4 2024, compared to 79 in Q4 2023 and 124 in Q3 2024 [20] Revenue Guidance - The company projects Q1 2025 revenue growth of 45-55% compared to Q1 2024 revenue of $5.79 million [23] - The company forecasts FY 2025 revenue of $48-50 million, representing a 47-53% increase compared to FY 2024 revenue of $32.6 million [23]

Toll Free: 1-800-245-3047 Toll/International: 1-203-518-9765 Conference ID: SANUWAVE Q1 FY2025 May 9, 2025 Live Presentation Friday, May 9, 2025, 8:30 AM (ET) Participant Dial-in Information OR click the link for instant telephone access to the event. https://viavid.webcasts.com/starthere.jsp?ei=1714486&tp_key=88406b4795 Replay Dial-in Information Toll Free: 1-844-512-2921 Toll/International: 1-412-317-6671 Replay Pin Number: 11158734 Replay Expiry: May 30, 2025 2 Forward Looking Statements and Non-GAAP Fin ...

Q1 2025 revenues were $9.3 million, up 61% from $5.8 million in Q1 2024. This represents the highest Q1 quarterly revenues in Company history. Q1 2025 gross margin was 79.0%, versus 72.6% in Q1 2024. GAAP Operating Income was $1.0 million for Q1 2025, an increase of $2.0 million from Q1 2024. Company provides guidance for revenue growth of 40-50% for Q2 2025 as compared to Q2 2024 EDEN PRAIRIE, Minn., May 09, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a le ...

Sanuwave Health (SNWV) Q3 2024 Earnings Call November 08, 2024 08:30 AM ET Speaker0 Please note this call is being recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Morgan Frank, Chairman and CEO of Sanywave. Speaker1 Thank you very much. So welcome, everyone, to Sanywave's third quarter twenty twenty four earnings call. As many of you saw, our Form 10 Q was filed with the SEC last night. Our earnings release was issued this morning, a ...

Sanuwave Health (SNWV) Q1 2024 Earnings Call May 10, 2024 08:30 AM ET Speaker0 Please note that this call is being recorded, and I will be standing by should you need any assistance. It is now my pleasure to turn the conference over to Morgan Frank. Please go ahead. Speaker1 Thank you very much. Hi, everyone, and welcome to TANUWAVE's first quarter twenty twenty four earnings call. As many of you probably saw, our Form 10 Q was filed with the SEC Thursday night, and our earnings release was issued this morn ...

Sanuwave Health (SNWV) Q4 2023 Earnings Call March 22, 2024 08:30 AM ET Speaker0 note today's call will be recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Morgan Frank, Chairman and CEO of SANUWAVE. Please go ahead. Speaker1 Thanks very much. So welcome everyone to SANUWAVE's fourth quarter and fiscal twenty twenty three earnings call. Our form 10 k was filed with the SEC last night. Our earnings release was issued this morning, and ...

Sanuwave Health (SNWV) Q3 2023 Earnings Call November 10, 2023 08:00 AM ET Speaker0 Greetings. Welcome to Sandy Wave Announces Third Quarter Results. At this time, all participants are in listen only mode. A question and answer session will follow the formal presentation. Please note this conference is being recorded. At this time, I'll turn the conference over to Morgan Frank, Chairman and CEO of SANUWAVE. Morgan, you may begin. Speaker1 Thank you. Good morning and welcome to SANUWAVE's third quarter twent ...

Sanuwave Health (SNWV) Q1 2023 Earnings Call May 12, 2023 09:00 AM ET Speaker0 Greetings, and welcome to the SanuWave Health business update conference call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Kevin Richardson, Chief Executive Officer. Thank you, sir. You may begin. Speaker1 Thank you, Christine. Welcome to SANUWAVE's ...